Structured evidence table for Lactobacillus Plantarum Exercise Performance Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Lactobacillus Plantarum Exercise Performance Randomized Trial | However, existing evidence does not prove that microbiome changes are a direct source of these adaptations as exercise, food, and other host factors may all contribute at the same time (). | 3 | Zhang Xinbao (2026) | Microbiome-based nutrition and the gut–muscle axis: emerging perspectives for athletic performance and recovery |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | Bioactive plant chemicals called polyphenols, which are found in large quantities in fruits, vegetables, and teas, additionally regulate this relationship by selectively enriching and functioning as prebiotic substrates (). | 3 | Zhang Xinbao (2026) | Microbiome-based nutrition and the gut–muscle axis: emerging perspectives for athletic performance and recovery |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | SCFAs may affect AMPK, PGC-1α, and associated metabolic pathways, according to experimental studies. | 3 | Zhang Xinbao (2026) | Microbiome-based nutrition and the gut–muscle axis: emerging perspectives for athletic performance and recovery |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | 1 2 3 4 The dynamic interaction of training load, recuperation, diet, and biological resilience determines athletic efficiency. | 3 | Zhang Xinbao (2026) | Microbiome-based nutrition and the gut–muscle axis: emerging perspectives for athletic performance and recovery |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | 9 11 12 13 14 15 16 Prevotella Faecalibacterium Eubacterium Studies have shown that muscle mass and strength are strongly associated with the composition of GM (–). | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | For instance, recent systematic reviews have reported a significant association between reduced GM diversity and the occurrence of sarcopenia, and the reduction of some specific bacteria, such asandmight be associated with muscle loss (,). | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | Moreover, in patients with chronic diseases such as heart failure and chronic kidney disease, changes in the GM are also closely associated with sarcopenia, which further supporting the concept of the gut-muscle axis (,). | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
| Lactobacillus Plantarum Exercise Performance Randomized Trial | 1 2 3 Sarcopenia is an age-related condition characterized by generalized loss of skeletal muscle mass, strength, and physical function, which has a negative impact on the life quality and health status of elderly individuals. | 3 | Liu Yikai (2026) | Gut-muscle axis in sarcopenia: from mechanisms to microbiome-based therapies |
Source documents